Company Profiles

driven by the PitchBook Platform

Accuronix Therapeutics

Description

Developer of novel therapies designed to solve most difficult problems in cancer therapy. The company's novel therapies is based on technology that selectively targets σ-2 receptors overexpressed on cancer cells, enabling doctors to increase efficacy and reduce toxicity risk.

2015

Founded

PRIVATE

Status

Early Stage VC

Latest Deal Type

$625k

Latest Deal Amount

$650k

Total Amount Raised

2

Investors

Description

Developer of novel therapies designed to solve most difficult problems in cancer therapy. The company's novel therapies is based on technology that selectively targets σ-2 receptors overexpressed on cancer cells, enabling doctors to increase efficacy and reduce toxicity risk.

Website:

www.accuronix.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

20 South Sarah Street Saint Louis, MO 63108United States
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Accuronix Therapeutics's full profile, request a free trial.

    Accuronix Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Accuronix Therapeutics Investors (2)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    BioGeneratorNot-For-Profit Venture CapitalMinority000 0000000 0000
    Missouri TechnologyVenture CapitalMinority000 0000000 0000
    BioGenerator Not-For-Profit Venture Capital
    Missouri Technology Venture Capital

    Accuronix Therapeutics Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    Dennis SchaferChief Executive Officer & President
    Linda LawVice President, Clinical Development & CMO
    Robert Mach Ph.DCo-Founder
    William HawkinsCo-Founder
    Dennis Schafer Chief Executive Officer & President
    Linda Law Vice President, Clinical Development & CMO
    Robert Mach Ph.D Co-Founder
    William Hawkins Co-Founder

    Accuronix Therapeutics Board Members (1)

    NameRepresentingRoleSinceContact
    Info
    Charles BoltenBioGeneratorVice President000 0000
    Charles Bolten Vice President BioGenerator
    Request full access to PitchBook